UNIVERSITY OF WASHINGTON

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1861-01-01

Employees: 10K

Market Cap: -

Website: https://www.cs.washington.edu

Clinical Trials

Transcranial Magnetic Stimulation for Treating Women With Chronic Widespread Pain

Phase 2

Completed

Conditions: Fibromyalgia
Chronic Pain
Depression

Interventions: Device: rTMS
Device: Sham rTMS

First Posted Date: 2007-09-03

Last Posted Date: 2013-05-23

Lead Sponsor: University of Washington

Target Recruit Count: 19

Registration Number: NCT00524420

Locations: 🇺🇸
Harborview Medical Center, Seattle, Washington, United States

Exercise After an ICD

Phase 2

Completed

Conditions: Heart Failure, Congestive
Defibrillators, Implantable

Interventions: Behavioral: Aerobic Exercise Program

First Posted Date: 2007-08-29

Last Posted Date: 2014-11-10

Lead Sponsor: University of Washington

Target Recruit Count: 160

Registration Number: NCT00522340

Locations: 🇺🇸
University of Washington, Seattle, Washington, United States

Randomized Trial of Advanced Provision Emergency Contraception Among Women With Gonorrhea or Chlamydia

Not Applicable

Completed

Conditions: Pregnancy

Interventions: Drug: levonorgestrel 0.75mg taken twice 12 hours apart (Plan B) and condoms

First Posted Date: 2007-08-24

Last Posted Date: 2007-11-15

Lead Sponsor: University of Washington

Target Recruit Count: 177

Registration Number: NCT00520455

Locations: 🇺🇸
Public Health - Seattle & King County STD Clinic, Seattle, Washington, United States

Sunitinib Malate in Treating Patients With Iodine-Refractory Recurrent or Metastatic Thyroid Cancer

Phase 2

Completed

Conditions: Recurrent Thyroid Cancer
Stage IVA Follicular Thyroid Cancer
Stage IVA Papillary Thyroid Cancer
Stage IVB Follicular Thyroid Cancer
Stage IVB Papillary Thyroid Cancer
Stage IVC Follicular Thyroid Cancer
Stage IVC Papillary Thyroid Cancer
Thyroid Gland Medullary Carcinoma

Interventions: Drug: sunitinib malate

First Posted Date: 2007-08-23

Last Posted Date: 2017-04-25

Lead Sponsor: University of Washington

Target Recruit Count: 35

Registration Number: NCT00519896

Locations: 🇺🇸
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States

Sunitinib Malate, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide Before Surgery in Treating Patients With Stage IIB-IIIC Breast Cancer

Phase 2

Completed

Conditions: Stage II Breast Cancer
Inflammatory Breast Cancer
Male Breast Cancer
Stage IIIC Breast Cancer
Stage IIIA Breast Cancer
Stage IIIB Breast Cancer

Interventions: Drug: sunitinib malate
Drug: paclitaxel
Drug: doxorubicin hydrochloride
Drug: cyclophosphamide
Biological: filgrastim
Procedure: therapeutic conventional surgery
Other: laboratory biomarker analysis
Other: flow cytometry

First Posted Date: 2007-08-09

Last Posted Date: 2019-08-07

Lead Sponsor: University of Washington

Target Recruit Count: 68

Registration Number: NCT00513695

Locations: 🇺🇸
Skagit Valley Hospital, Mount Vernon, Washington, United States
🇺🇸
Olympic Medical Center, Port Angeles, Washington, United States
🇺🇸
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States

and more 4 locations

Evaluating the Collaborative Management in Pediatrics (CMP) Training Program Among Pediatric Resident Doctors and Their Patients With Asthma or Obesity

Not Applicable

Completed

Conditions: Education
Asthma
Obesity

Interventions: Behavioral: Collaborative Management in Pediatrics (CMP) Program

First Posted Date: 2007-08-02

Last Posted Date: 2012-12-20

Lead Sponsor: University of Washington

Target Recruit Count: 18

Registration Number: NCT00510341

Locations: 🇺🇸
Harborview's Children and Teens Clinic, Seattle, Washington, United States
🇺🇸
Pediatric Care Center, Seattle, Washington, United States
🇺🇸
Odessa Brown Children's Clinic, Seattle, Washington, United States

Empiric Therapy of Helminth Co-infection to Reduce HIV-1 Disease Progression

Not Applicable

Completed

Conditions: HIV Infections
Helminthiasis

Interventions: Drug: Current standard of care in Kenya
Drug: Albendazole
Drug: Praziquantel

First Posted Date: 2007-07-26

Last Posted Date: 2014-11-20

Lead Sponsor: University of Washington

Target Recruit Count: 948

Registration Number: NCT00507221

Locations: 🇰🇪
Kenya Medical Research Institute, Nairobi, Kenya

Role of CYP2B6, CYP3A4, and MDR1 in the Metabolic Clearance of Methadone

Phase 1

Conditions: Substance-Related Disorders

First Posted Date: 2007-07-20

Last Posted Date: 2010-10-13

Lead Sponsor: University of Washington

Target Recruit Count: 20

Registration Number: NCT00504413

Locations: 🇺🇸
University of Washington General Clinical Research Center, Seattle, Washington, United States

Randomized Clinical Trial of Nasal Turbinate Reduction to Improve Continuous Positive Airway Pressure (CPAP) Outcomes for Sleep Apnea

Phase 2

Completed

Conditions: Turbinate Hypertrophy
Sleep Apnea Syndromes
Nasal Obstruction

Interventions: Procedure: Radiofrequency Turbinate Reduction
Procedure: Sham RF

First Posted Date: 2007-07-19

Last Posted Date: 2013-06-19

Lead Sponsor: University of Washington

Target Recruit Count: 242

Registration Number: NCT00503802

Locations: 🇺🇸
Virginia Mason Medical Center, Seattle, Washington, United States
🇺🇸
UW Sleep Disorders Center at Harborview Medical Center, Seattle, Washington, United States
🇺🇸
University of Washington General Clinical Research Center, Seattle, Washington, United States

Starting Healthy Staying Healthy Pilot Trial

Not Applicable

Completed

Conditions: Obesity

Interventions: Behavioral: TV modification
Behavioral: safety and injury prevention

First Posted Date: 2007-07-18

Last Posted Date: 2009-11-20

Lead Sponsor: University of Washington

Target Recruit Count: 70

Registration Number: NCT00503074

Locations: 🇺🇸
Child Health Institute, University of Washington, Seattle, Washington, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy